Atlas Trials

Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.

Clinical trial NCT02579941 · COMPLETED

Trial details

NCT number
NCT02579941
Sponsor
Brugmann University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hyperfibrinolysis
Start date
2015-11-01
Primary completion
2016-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.